http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113185599-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P1-00
filingDate 2021-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113185599-B
titleOfInvention Antibacterial peptide targeting staphylococcus aureus and preparation method and application thereof
abstract The invention provides an antibacterial peptide targeting staphylococcus aureus, a preparation method and application thereof. The sequence of the antibacterial peptide F6 is shown in SEQ ID No. 1. The invention takes the 119-132 fragment of the human myeloid protein MD-2 as a basic fragment and utilizes the leucine site-directed mutagenesis technology to construct the antibacterial peptide F6 targeting gram-positive bacteria. In a minimum inhibitory concentration test and a single bacteria culture system antibacterial test, the F6 polypeptide shows extremely strong antibacterial ability against staphylococcus aureus and no gram-negative bacteria ability. In a selective sterilization test of a mixed system, F6 can preferentially kill staphylococcus aureus and has almost no influence on escherichia coli, which shows the potential of the F6 as a specific gram-positive bacteria resistant antibacterial drug and a specific gram-positive bacteria resistant polypeptide molecular probe.
priorityDate 2021-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411319929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411320023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7019083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71077
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID448830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426130707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17087
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7022320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411320031
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID193508
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7021820
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23643
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID562
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426130833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059

Total number of triples: 43.